Shukra Pharmaceuticals Ltd receives LoA from RMSCL

Shukra Pharmaceuticals Limited has received a Letter of Acceptance dated June 24, 2025, from Rajasthan Medical Services Corporation Limited (RMSCL), signifying the Company's successful bid under Tender Ref No. F.02(412)/RMSCL/PROCUREMENT/DRUG/NIB-10/2024/1396.

Under this tender, the Company has been awarded a Rate Contract cum Supply Agreement for the supply of essential pharmaceutical formulations to government health institutions across Rajasthan. The total contract value aggregates to 11.59 Crore, with supplies scheduled to be completed by December 2026.

This prestigious contract reinforces Shukra Pharmaceuticals' reputation as a trusted healthcare partner in the public sector and reflects the Company's growing capabilities in large-scale institutional supply. The Company is currently finalizing the required formalities, including execution of the agreement and submission of the stipulated performance security.

We believe this development will significantly enhance our visibility in the institutional segment and contribute meaningfully to our revenue pipeline over the coming quarters. This achievement aligns with our broader strategic vision of expanding our footprint in government procurement channels and delivering long-term value to our shareholders.

Source : Equity Bulls

Keywords

ShukraPharmaceuticals LoA OrderWin RMSCL